Início » REFERÊNCIAS

REFERÊNCIAS

  1. Agarwal A, Deepinder F, Cocuzza M, Short RA, Evenson DP. Effect of vaginal lubricants on sperm motility and chromatin integrity: a prospective comparative study. Fertil Steril. 2008 Feb;89(2):375–379.
  2. Akmal M, Qadri JQ, Al-Waili NS, Thangal S, Haq A, Saloom KY. Im- provement in human semen quality after oral supplementation of vitamin C. J Med Food. 2006 Fall; 9(3):440-2.
  3. Alviggi C, Humaidan P, Ezcurra D. Hormonal, functional and genetic biomarkers in controlled ovarian stimulation: tools for match- ing patients and protocols. Reprod Biol Endocrinol. 2012 Feb 6;10:9.
  4. Badawy ZS, Chohan KR, Whyte DA, Penefsky HS, Brown OM, Souid AK. Cannabinoids inhibit the respiration of human sperm. Fertil Steril. 2009 Jun;91(6):2471–2476.
  5. Balercia G, Mancini A, Paggi F, et al. Coenzyme Q10 and male infer- tility. J Endocrinol Invest. 2009 Jul;32(7):626–632.
  6. Barbieri RL. Infertility, empirical therapy for infertility. In: Yen SSC, Jaffe RV, Barbieri RL, editors. Reproductive endocrinology. 4th ed. Philadelphia: W.B. Saunders Company; 1999. pp. 585–587.
  7. Bari M, Battista N, Pirazzi V, Maccarrone M. The manifold actions of endocannabinoids on female and male reproductive events. Front Biosci. 2011 Jan 1;16:498–516.
  8. Bonetti A, Tirelli F, Catapano A, et al. Side effects of anabolic andro- genic steroids abuse. Int J Sports Med. 2008 Aug;29(8):679–687.
  9. Borges WC, Borges WP, Costa Z. Propedêutica : Fator Feminino. In: Dizik A, Pereira D, Cavagna M, Amaral W. eds. Tratado de Reprodução Assistida. São Paulo: segmento Farma, 2010. pp. 37-48.
  10. Braga DP, Halpern G, Figueira Rde C, Setti AS, Iaconelli A Jr, Bor- ges E Jr. Food intake and social habits in male patients and its relationship to intracytoplasmic sperm injection outcomes. Fertil Steril. 2012 Jan;97(1):53–59.
  11. Broer SL, Mol BW, Hendriks D, Broekmans FJ. The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril. 2009 Mar;91(3):705-14.
  12. Broer SL, Dólleman M, Opmeer BC, Fauser BC, Mol BW, Broek- mans FJ. AMH and AFC as predictors of excessive response in con- trolled
    ovarian hyperstimulation: a meta-analysis. Hum Reprod Update. 2011 Jan-Feb;17(1):46-54.
  13. Campagne DM. Can Male Fertility Be Improved Prior to Assisted Reproduction through The Control of Uncommonly Considered Factors? Int J Fertil Steril. 2013 Jan;6(4):214-223.
  14. Committee on Gynecologic Practice of the American College of Obstetricians and Gynecologists, The Practice Committee of the Ameri- can Society of Reproductive Medicine. Age-related fertility decline: a committee opinion. Fertil Steril. 2008 Nov;90(Suppl 5):S154-5.
  15. Coutifaris C, Myers E, Guzick DS et al. Histological dating of timed endometrial biopsy tissue is not related to fertility status. Fertil Ste- ril. 2004 Nov;82(5):264–1272.
  16. Creasy, RK, Resnik R. Creasy and Resnik’s Maternal-Fetal Medicine: Principles and Practice. Philadelphia: Ed. WB Saunders, 1994:71.
  17. Dondorp W, de Wert G, Pennings G, et al. Lifestyle-related factors and access to medically assisted reproduction. Hum Reprod. 2010 Mar;25(3):578–583.
  18. Dzik A, Banzato P, Miklos T. Reserva Ovariana. In: Dizik A, Pereira D, Cavagna M, Amaral W. eds. Tratado de Reprodução Assistida. São Paulo: segmento Farma, 2010. pp. 83-90. 19.
  19. Esposito MA, Coutifaris C, Barnhart KT. A moderately elevated day 3 FSH concentration has limited predictive value, especially in younger women. Hum Reprod. 2002 Jan;17(1):118-23.
  20. Farhi J, Ben-Haroush A. Distribution of causes of infertility in patients attending primary fertility clinics in Israel. Isr Med Assoc J. 2011 Jan;13(1):51–54.
  21. Fleming R, Kelsey TW, Anderson RA, Wallace WH, Nelson SM. Interpreting human follicular recruitment and antimüllerian hormone concentrations throughout life. Fertil Steril. 2012 Nov;98(5):1097-102.
  22. Fronczak CM, Kim ED, Barqawi AB. The insults of recreational drug abuse on male fertility. J Androl. 2012 Jul-Aug;33(4):515–528.
  23. Gindoff PR, Jewelewicz R. Reproductive potential in the older woman. Fertil Steril. 1986 Dec;46(6):989-1001.
  24. Hazout A, Bouchard P, Seifer DB et al. Serum antimüllerian hormone/müllerianinhibiting substance appears to be a more discrimina- tory marker of assisted reproductive technology outcome than folli- cle-stimulating hormone, inhibin B, or estradiol. Fertil Steril. 2004 Nov;82(5):1323–1329.
  25. Hendriks DJ, Mol BW, Bancsi LF et al. Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fer- tilization: a meta-analysis and comparison with basal follicle-stimu- lating hormone level. Fertil Steril, 2005 Feb;83(2):291–301.
  26. La Marca A, Broekmans FJ, Volpe A, Fauser BC, Macklon NS; ESH- RE Special Interest Group for Reproductive Endocrinology-AMH Round Table. AntiMullerian hormone (AMH): what do we still need to know? Hum Reprod. 2009 Sep;24(9):2264-75.
  27. La Marca A, Sighinolfi G, Radi D et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010 Mar-Apr;16(2):113–130.
  28. La Marca A, Stabile G, Artenisio AC, Volpe A. Serum anti-Mullerian hormone throughout the human menstrual cycle. Hum Reprod. 2006 Dec;21(12):3103-7
  29. Ledger WL. Clinical utility of measurement of anti-mullerian hormone in reproductive endocrinology. J Clin Endocrinol Metab. 2010
    Dec;95(12):5144–5154.
  30. Lessey BA. Assessment of endometrial receptivity. Fertil Steril. 2011 Sep;96(3):522–529.
  31. Maneesh M, Dutta S, Chakrabarti A, Vasudevan DM. Alcohol abuse – duration dependent decrease in plasma testosterone and antioxidants in males. Indian J Physiol Pharmacol. 2006 Jul- -Sep;50(3):291–296.
  32. McLean M, Wellons MF. Optimizing natural fertility: the role of lifestyle modification. Obstet Gynecol Clin North Am. 2012 Dec;39(4):465-77.
  33. Nelson SM, Yates RW, Lyall H, Jamieson M, Traynor I, Gaudoin M, Mitchell P, Ambrose P, Fleming R. Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception. Hum Reprod. 2009 Apr;24(4):867-75.
  34. Nelson SM. Biomarkers of ovarian response: current and future applications. Fertil Steril. 2013 Mar 15;99(4):963-9.
  35. Nudell DM, Monoski MM, Lipshultz LI. Common medications and drugs: how they affect male fertility. Urol Clin North Am. 2002 Nov;29(4):965–973.
  36. Practice Committee of American Society for Reproductive Medicine in collaboration with Society for Reproductive Endocrinology and
    Infertility. Optimizing natural fertility practice guideline. Fertil Steril. 2013 Sep;100(3):631-7.
  37. Practice Committee of the American Society of Reproductive MedicineCommittee opinion: role of tubal surgery in the era of assisted reproductive technology. Fertil Steril. 2012 Mar;97(3):539–545.
  38. Practice Committee of the American Society of Reproductive Medicine and The Society of Reproductive Surgeons Myomas and re- productive function. Fertil Steril. 2008 Nov;90(Suppl 5):S125–S130.
  39. Practice Committee of the American Society of Reproductive Me- dicine Diagnostic evaluation of the infertile male: a committee opi- nion. Fertil Steril. 2012 Aug;98(2):294-301.
  40. Ramlau-Hansen CH, Thulstrup AM, Aggerholm AS, Jensen MS, Toft G, Bonde JP. Is smoking a risk factor for decreased semen qual- ity? A cross-sectional analysis. Hum Reprod. 2007 Jan;22(1):188–196.
  41. Safarinejad MR, Azma K, Kolahi AA. The effects of intensive, long-term treadmill running on reproductive hormones, hypothalamus-pituitary-testis axis, and semen quality: a randomized controlled study. J Endocrinol. 2009 Mar;200(3):259–271.
  42. Schettler T. An ecological view of health. Explore (NY). 2006 Jul- -Aug;2(4):357-60.
  43. Tremellen K, Miari G, Froiland D, Thompson J. A randomised control trial examining the effect of an antioxidant (Menevit) on preg- nancy outcome during IVF-ICSI treatment. Aust N Z J Obstet Gy- naecol. 2007 Jun;47(3):216–221.
  44. Tso L, Duarte Filho O. Epidemiologia da Infertilidade. In: Dizik A, Pereira D, Cavagna M, Amaral W. eds. Tratado de Reprodução As- sistida. São Paulo: segmento Farma, 2010. pp. 1-9.
  45. Vargas J, Crausaz M, Senn A, Germond M. Sperm toxicity of “non- spermicidal” lubricant and ultrasound gels used in reproductive medicine. Fertil Steril. 2011 Feb;95(2):835–836.
  46. Vaziri MH, Sadighi Gilani MA, Kavousi A, et al. Occupational haz- ards and male infertility. Int J Fertil Steril. Jul;5(2):66-71.
  47. Vine MF. Smoking and male reproduction: a review. Int J Androl. 1996 Dec;19(6):323–337.
  48. Walczak-Jedrzejowska R, Wolski JK, Slowikowska-Hilczer J. The role of oxidative stress and antioxidants in male fertility. Cent Euro- pean J Urol. 2013;66(1):60-67.
  49. Wirth JJ, Mijal RS. Adverse effects of low level heavy metal exposure on male reproductive function. Syst Biol Reprod Med. 2010 Apr;56(2):147–167.
  50. Zitzmann M, Rolf C, Nordhoff V, et al. Male smokers have a de- creased success rate for in vitro fertilization and intracytoplasmic sperm injection. Fertil Steril. 2003 Jun;79 Suppl 3:1550–1554.
Valores e Dúvidas sobre os
Tratamentos
Tire suas dúvida e saibas os valores dos nossos tratamentos